20,000+ Scientists & Academics
4,000+ Scientific disciplines
20,000+ Projects posted
Trusted by 3,200+ businesses
Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss the project scope and fee and hire the expert who best meets your requirements
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but release the funds only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Contact
★★★★★
☆☆☆☆☆
Hire Dr. Salil Putatunda
India

A Chemist having extensive experience in Pharma R&D Industry. Capable of executing multi-step organic synthesis projects

Profile Summary
Subject Matter Expertise
Services
Work Experience

Senior Scientific Officer

Sapala Organics Pvt. Ltd.

July 2020 - Present

Senior Scientist - B

Onium Lifesciences Pvt. Ltd.

April 2019 - June 2020

Research Chemist

TCG Lifesciences Pvt. Ltd.

February 2006 - March 2009

Education

Postdoctoral Research Fellow (Department of Organic Chemistry)

Univerzita Karlova v Praze (Charles University in Prague)

January 2017 - Present

Doctor of Philosophy (Department of Chemistry)

University of Calcutta

March 2009 - December 2014

Certifications
  • Certification details not provided.
Publications
JOURNAL ARTICLE
Salil Putatunda, Aparajita Ghosh, Arijit Bhowmik, Suman Bhandary, Aparna Laskar, Atanu Biswas, Sandip Dolui, Bhaswati Banerjee, Rajni Khan, Nirmalendu Das, et al.(2016). Formulation and antitumorigenic activities of nanoencapsulated nifetepimine: A promising approach in treating triple negative breast carcinoma . Nanomedicine: Nanotechnology, Biology and Medicine. 12. (7). p. 1973--1985. Elsevier {BV}
Ghosh, A., Bhowmik, A., Bhandary, S., Putatunda, S., Laskar, A., Biswas, A., Dolui, S., Banerjee, B., Khan, R., Das, N., et al.(2016). Formulation and antitumorigenic activities of nanoencapsulated nifetepimine: A promising approach in treating triple negative breast carcinoma . Nanomedicine: Nanotechnology, Biology, and Medicine. 12. (7). p. 1973-1985.
Ghosh, S., Adhikary, A., Chakraborty, S., Bhattacharjee, P., Mazumder, M., Putatunda, S., Gorain, M., Chakraborty, A., Kundu, G.C., Das, T., et al.(2015). Cross-talk between endoplasmic reticulum (ER) stress and the MEK/ERK pathway potentiates apoptosis in human triple negative breast carcinoma cells: Role of a dihydropyrimidone, nifetepimine . Journal of Biological Chemistry. 290. (7). p. 3936-3949.
Salil Putatunda, Swatilekha Ghosh, Arghya Adhikary, Supriya Chakraborty, Pushpak Bhattacharjee, Minakshi Mazumder, Mahadeo Gorain, Arijit Chakraborty, Gopal C. Kundu, Tanya Das, et al.(2014). Cross-talk between Endoplasmic Reticulum ({ER}) Stress and the {MEK}/{ERK} Pathway Potentiates Apoptosis in Human Triple Negative Breast Carcinoma Cells . Journal of Biological Chemistry. 290. (7). p. 3936--3949. American Society for Biochemistry {\&} Molecular Biology ({ASBMB})
Salil Putatunda, Srabasti Chakraborty, Swatilekha Ghosh, Pinki Nandi, Supriya Chakraborty, Parimal C. Sen, Arijit Chakraborty(2012). {ChemInform} Abstract: Regioselective N1-Alkylation of 3,4-Dihydropyrimidine-2(1H)-ones: Screening of Their Biological Activities Against Ca 2$\mathplus$ -{ATPase} . {ChemInform}. 43. (50). p. no--no. Wiley-Blackwell
Putatunda, S., Chakraborty, S., Ghosh, S., Nandi, P., Chakraborty, S., Sen, P.C., Chakraborty, A.(2012). Regioselective N1-alkylation of 3,4-dihydropyrimidine-2(1H)-ones: Screening of their biological activities against Ca <sup>2+</sup> -ATPase . European Journal of Medicinal Chemistry. 54. p. 223-231.
Ghosh, S., Adhikary, A., Chakraborty, S., Nandi, P., Mohanty, S., Chakraborty, S., Bhattacharjee, P., Mukherjee, S., Putatunda, S., Chakraborty, S., et al.(2012). Nifetepimine, a dihydropyrimidone, ensures CD4 <sup>+</sup> T cell survival in a tumor microenvironment by maneuvering Sarco(endo)plasmic reticulum Ca <sup>2+</sup> ATPase (SERCA) . Journal of Biological Chemistry. 287. (39). p. 32881-32896.